Cohort Studies
2025. Anticholinergic drug exposure is associated with prevalence, worsening and incidence of dysphagia among hospitalized older adults. The journal of nutrition, health & aging. 29 (5) 100507.
Google Scholar
2024. The prevalence of non-pharmacological interventions in older homecare recipients: an overview from six European countries. European geriatric medicine. 15 (1) 243-252.
Google Scholar
2024. The Drug Burden Index and Level of Frailty as Determinants of Healthcare Costs in a Cohort of Older Frail Adults in New Zealand. Value Health Reg Issues. 41 () 72-79.
Google Scholar
2024. Social Activity and Cognitive Decline in Older Residents of Long-Term Care Facilities: A Cohort Study. Journal of Alzheimer's disease : JAD. 98 (2) 433-443.
Google Scholar
2023. Agreement and prognostic accuracy of three ED vulnerability screeners: findings from a prospective multi-site cohort study. Canadian Journal of Emergency Medicine. 25 (3) 209-217.
Google Scholar
2023. Development and validation of risk of CPS decline (RCD): a new prediction tool for worsening cognitive performance among home care clients in Canada. BMC geriatrics. 23 (1) 792.
Google Scholar
2020. Prevalence and risk factors of breathlessness across Canada: A national retrospective cohort study in home care and nursing home populations. Journal of Pain and Symptom Management. 62 (2) 346-354e1.
Google Scholar
2020. Impact of anticholinergic burden on cognitive performance: a cohort study of community-dwelling older adults. Journal of the American Medical Directors Association. 21 (9) 1357.
Google Scholar
2020. Frailty Index and functional level upon admission predict hospital outcomes: an interRAI-based cohort study of older patients in post-acute care hospitals. BMC Geriatrics. 20 (1) 160.
Google Scholar
2020. A Canadian cohort study to evaluate the outcomes associated with a multicenter initiative to reduce antipsychotic use in long-term care homes. Journal of the American Medical Directors Association. 21 (6) 817-822.
Google Scholar